Europe
Sarepta’s Exondys 51 hit with negative CHMP opinion in Duchenne muscular dystrophy
September 24, 2018Research and Development, Sales and Marketing CHMP, Duchenne Muscular Dystophy, EMA, Europe, Exondys 51, pharma, sarepta
Sarepta Therapeutics has been rocked by a hurdle in its pursuit of regulatory approval in Europe, as the company revealed …
EU approval for Mylan and Fujifilm’s Humira biosimilar
September 21, 2018Medical Communications, Sales and Marketing EU, Europe, Humira, Mylan, biosimilar, pharma
The European Commission has approved its fifth biosimilar of the world’s best-selling drug, Abbvie’s Humira (adalimumab), granting marketing authorisation to …
Drug safety: UK and EU post-Brexit
September 10, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, Europe, MHRA, UK, brexit, drug safety, pharmacovigilance
What does Brexit mean for drug safety in Europe and the United Kingdom? Louis Goss looks into Britain’s exit from …
Keytruda scores ground-breaking European approval in lung cancer subgroup
September 10, 2018Sales and Marketing Cancer, EU, Europe, MSD, Merck, NSCLC, keytruda, lung cancer, pharma
Keytruda (pembrolizumab) has chalked up yet another approval for MSD, this time in Europe in combination with permextred and platinum-based …
Europe-wide policy could boost generics market, study suggests
September 5, 2018Research and Development Europe, generics, growth, markets, pharma
A Europe-wide policy covering the generic pharmaceutical market would facilitate significant growth in the pharmaceutical sector according to a new …
European Commission authorises first-ever rare blood condition drug
September 4, 2018Manufacturing and Production, Sales and Marketing Europe, Sanofi, approvals, cablivi, eu commission
Sanofi have announced that the European Commission granted marketing authorisation for Cablivi (caplacizumab) for the treatment of adults experiencing an …
Europe approves Janssen’s Darzalex in frontline multiple myeloma
September 4, 2018Manufacturing and Production, Research and Development, Sales and Marketing EU, Europe, J&J, JJ, Janssen, darzalex, multiple myeloma, pharma
Janssen has revealed that its CD38-targeting biologic drug Darzalex (daratumumab) has received approval from the European Commission, authorising its use …
AstraZeneca’s once-weekly auto-injector Bydureon BCise wins EU approval in type 2 diabetes
August 30, 2018Research and Development, Sales and Marketing AstraZeneca, Bydureon, EU, Europe, diabetes, pharma, type 2 diabetes
AstraZeneca has announced that its auto-injector Bydureon BCise (exenatide 2mg prolonged-release suspension) has been approved by the European Commission for …
Novartis migraine prevention drug scores EU approval
July 31, 2018Manufacturing and Production, Sales and Marketing Aimovig, Europe, Novartis, migraine, pharma
Novartis is celebrating the news that its calcitonin gene-related peptide receptor (CGRP-R) pathway therapy Aimovig (erenumab) has been approved by …
European cannabis market set to be worth €115.7 billion by 2028
July 16, 2018Sales and Marketing Europe, Legislation, cannabis, medicinal marijuana
The European cannabis market is set to be worth €115.7 billion by 2028, according to a report released by the …
EMA issues global recall of heart drugs over cancer risk contamination
July 10, 2018Manufacturing and Production EMA, Europe, heart disease, pharma, valsartan
Several drugs designed for the treatment of high blood pressure and heart conditions have been recalled across Europe over fears …
MSD’s ulcerative colitis drug scores expanded indication in Europe
July 9, 2018Sales and Marketing Europe, MSD, pharma, ulcerative colitis
New Jersey-based multinational MSD have announced that the European Commission (EC) has approved Simponi (golimumab) for early dose optimisation in …
Pfizer’s Xeljanz scores EU approval for active psoriatic arthritis
June 29, 2018Medical Communications, Sales and Marketing EU, Europe, Pfizer, Xeljanz, pharma, psoriatic arthritis
Pfizer has announced that the European Commission (EC) has approved Xeljanz in combination with methotrexate (MTX) for the treatment of …
European Commission greenlights Gilead’s Biktarvy for HIV-1
June 25, 2018Sales and Marketing Biktarvy, EU, Europe, European Commission, HIV, HIV-1, pharma
Good news for Gilead and HIV patients across the European Union today as the prominent pharma firm announced that its …
AB Science will not seek review of masitinib rejection in Europe
May 29, 2018Manufacturing and Production, Sales and Marketing EMA, Europe, ab science, als, masitinib, pharma
AB Science has U-turned on its pursuit of a do-over on its marketing application of masitinib in Europe after the …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
